Cambria Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $583K | Buy |
5,498
+3,103
| +130% | +$329K | 0.04% | 224 |
|
|
2025
Q1 | $297K | Sell |
2,395
-1,759
| -42% | -$218K | 0.02% | 302 |
|
|
2024
Q4 | $512K | Hold |
4,154
| – | – | 0.03% | 227 |
|
|
2024
Q3 | $463K | Buy |
4,154
+314
| +8% | +$35K | 0.03% | 189 |
|
|
2024
Q2 | $410K | Sell |
3,840
-552
| -13% | -$58.9K | 0.03% | 206 |
|
|
2024
Q1 | $529K | Sell |
4,392
-1,558
| -26% | -$188K | 0.03% | 198 |
|
|
2023
Q4 | $732K | Hold |
5,950
| – | – | 0.05% | 149 |
|
|
2023
Q3 | $770K | Hold |
5,950
| – | – | 0.06% | 143 |
|
|
2023
Q2 | $738K | Sell |
5,950
-782
| -12% | -$96.9K | 0.06% | 145 |
|
|
2023
Q1 | $985K | Sell |
6,732
-748
| -10% | -$109K | 0.08% | 141 |
|
|
2022
Q4 | $1.19M | Buy |
7,480
+374
| +5% | +$59.6K | 0.1% | 161 |
|
|
2022
Q3 | $947K | Sell |
7,106
-374
| -5% | -$49.8K | 0.1% | 143 |
|
|
2022
Q2 | $1.17M | Hold |
7,480
| – | – | 0.15% | 135 |
|
|
2022
Q1 | $1.16M | Sell |
7,480
-1,317
| -15% | -$205K | 0.15% | 137 |
|
|
2021
Q4 | $1.12M | Sell |
8,797
-657
| -7% | -$83.7K | 0.19% | 139 |
|
|
2021
Q3 | $1.23M | Buy |
9,454
+438
| +5% | +$57K | 0.23% | 137 |
|
|
2021
Q2 | $1.6M | Buy |
+9,016
| New | +$1.6M | 0.28% | 134 |
|